US 8173615
TRPM-2 antisense therapy
granted A61KA61K31/00A61K31/337
Quick answer
US patent 8173615 (TRPM-2 antisense therapy) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/00, A61K31/337, A61K31/66, A61K31/704